These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 26263977)

  • 1. Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?
    Abdelhak A; Junker A; Brettschneider J; Kassubek J; Ludolph AC; Otto M; Tumani H
    Int J Mol Sci; 2015 Jul; 16(8):17565-88. PubMed ID: 26263977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF markers in amyotrophic lateral sclerosis.
    Tarasiuk J; Kułakowska A; Drozdowski W; Kornhuber J; Lewczuk P
    J Neural Transm (Vienna); 2012 Jul; 119(7):747-57. PubMed ID: 22555610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis.
    Takahashi K; Kurihara Y; Suzuki Y; Goshima Y; Tanaka F; Takei K
    JAMA Neurol; 2015 Feb; 72(2):176-9. PubMed ID: 25437093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cerebrospinal fluid tau protein in multiple sclerosis.
    Kapaki E; Paraskevas GP; Michalopoulou M; Kilidireas K
    Eur Neurol; 2000; 43(4):228-32. PubMed ID: 10828654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
    Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
    Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis.
    Wilke C; Deuschle C; Rattay TW; Maetzler W; Synofzik M
    Neurobiol Aging; 2015 Feb; 36(2):1072-4. PubMed ID: 25453560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis.
    Paladino P; Valentino F; Piccoli T; Piccoli F; La Bella V
    Eur J Neurol; 2009 Feb; 16(2):257-61. PubMed ID: 19138331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study.
    Zucchi E; Bedin R; Fasano A; Fini N; Gessani A; Vinceti M; Mandrioli J
    Neurodegener Dis; 2018; 18(5-6):255-261. PubMed ID: 30428468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis.
    Scarafino A; D'Errico E; Introna A; Fraddosio A; Distaso E; Tempesta I; Morea A; Mastronardi A; Leante R; Ruggieri M; Mastrapasqua M; Simone IL
    J Neurol; 2018 Oct; 265(10):2353-2362. PubMed ID: 30116940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis.
    Guimarães I; Cardoso MI; Sá MJ
    Mult Scler; 2006 Jun; 12(3):354-6. PubMed ID: 16764350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature.
    Gagliardi D; Meneri M; Saccomanno D; Bresolin N; Comi GP; Corti S
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical markers in CSF of ALS patients.
    Süssmuth SD; Brettschneider J; Ludolph AC; Tumani H
    Curr Med Chem; 2008; 15(18):1788-801. PubMed ID: 18691039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis.
    Barschke P; Oeckl P; Steinacker P; Ludolph A; Otto M
    Expert Rev Proteomics; 2017 Sep; 14(9):769-777. PubMed ID: 28799854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis.
    Brettschneider J; Maier M; Arda S; Claus A; Süssmuth SD; Kassubek J; Tumani H
    Mult Scler; 2005 Jun; 11(3):261-5. PubMed ID: 15957504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral Sclerosis.
    Andrés-Benito P; Povedano M; Domínguez R; Marco C; Colomina MJ; López-Pérez Ó; Santana I; Baldeiras I; Martínez-Yelámos S; Zerr I; Llorens F; Fernández-Irigoyen J; Santamaría E; Ferrer I
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33213069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
    Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal damage markers in cerebrospinal fluid are increased in ALS.
    Brettschneider J; Petzold A; Süssmuth SD; Ludolph AC; Tumani H
    Neurology; 2006 Mar; 66(6):852-6. PubMed ID: 16567701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyotrophic lateral sclerosis and primary lateral sclerosis: The role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers.
    Wang S; Melhem ER
    Ann N Y Acad Sci; 2005 Dec; 1064():61-77. PubMed ID: 16394148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid cytotoxicity does not affect survival in amyotrophic lateral sclerosis.
    Galán L; Matías-Guiu J; Matias-Guiu JA; Yáñez M; Pytel V; Guerrero-Sola A; Vela-Souto A; Arranz-Tagarro JA; Gómez-Pinedo U; García AG
    Acta Neurol Scand; 2017 Sep; 136(3):212-216. PubMed ID: 28032330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid biomarkers for Alzheimer's disease in patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis with the C9ORF72 repeat expansion.
    Kämäläinen A; Herukka SK; Hartikainen P; Helisalmi S; Moilanen V; Knuuttila A; Jansson L; Tienari PJ; Remes AM
    Dement Geriatr Cogn Disord; 2015; 39(5-6):287-93. PubMed ID: 25791939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.